Annals of Clinical and Translational Neurology

Papers
(The H4-Index of Annals of Clinical and Translational Neurology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease107
High‐dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury102
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study73
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes66
Cognitive impairment in pulmonary arterial hypertension64
Order from chaos: Using CSF proteomics to predict ALS progression63
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies56
Discrepant expressive language lateralization in children and adolescents with epilepsy54
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients51
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome50
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke50
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes48
Issue Information47
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels46
The case of a 49‐year‐old man with involuntary toe movements42
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states41
Association of serum Spp1 levels with disease progression in ALS and SBMA41
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation41
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study40
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica39
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration37
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA36
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D36
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression35
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan35
The case of a 60‐year‐old man with decline in job performance and changes in personality and judgment33
Peripheral nervous system manifestations of MOG antibody associated disease33
Issue Information32
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone32
Intracranial plaque with large lipid core is associated with embolic stroke of undetermined source31
A potential biomarker of cognitive impairment: The olfactory dysfunction and its genes expression31
Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience31
Correlation of slow‐wave sleep with motor and nonmotor progression in Parkinson's disease31
0.19568109512329